Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
95.22
(
-5.89%
)
Bitcoin
76,571.16
(
-0.91%
)
News Focus
News Focus
Post# of 890
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 149
Posts 26280
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: None

Wednesday, 11/19/2008 1:09:37 PM

Wednesday, November 19, 2008 1:09:37 PM

Post# of 890
The estimated cost for Elan to complete the Bapineuzumab phase III trial is approximately $150 million.

Elan does not need money right now. Elan needs to stay the course.

Good luck and God bless,

George
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote